EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trastuzumab Deruxtecan‐Induced Pneumonitis: Case Series

Abeer Alhuthali, Bushra Alqurashi, Yusra Banoun, Ziyad Almuylibi, Haneen Sait, Bayader Al-Sobhi, Mohammed Alnuhait iD

Clinical Case Reports · 2026-03 · 14 (3)

DOI: 10.1002/ccr3.72168 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Case Reports, online erschienen am 04.03.2026. Verfasst von Abeer Alhuthali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacy Department King Abdullah Medical City Makkah Saudi Arabia. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trastuzumab deruxtecan (T‐DXd) is a HER2‐targeted antibody–drug conjugate with proven efficacy in metastatic breast cancer, but interstitial lung disease (ILD) and drug‐induced pneumonitis are potentially life‐threatening toxicities. We retrospectively reviewed three patients with HER2‐positive metastatic breast cancer treated with T‐DXd at a tertiary hospital in Saudi Arabia who subsequently developed pneumonitis. Pneumonitis developed after 2–9 cycles of T‐DXd, presenting with cough, dyspnea, and ground‐glass opacities. All patients received corticosteroids and required permanent discontinuation. Early recognition and multidisciplinary management of T‐DXd‐induced pneumonitis are essential. Clinicians should monitor respiratory symptoms and apply timely corticosteroid therapy.

Schlagwörter

Stichwörter der Autor:innen

HER2‐positive breast cancerSaudi Arabiadrug‐induced pneumonitisinterstitial lung diseasetrastuzumab deruxtecan

Autor:innen und Institutionen

  • Clinical Pharmacy Department King Abdullah Medical City Makkah Saudi Arabia.
  • Clinical Pharmacy Department, College of Pharmacy Umm Al-Qura University Makkah Saudi Arabia.
  • Ministry of Health King Fahad Hospital Al-Baha Saudi Arabia.
  • Department of Clinical Pharmacy College of Pharmacy, Shaqra University, Al-Dawadmi Campus Al-Dawadmi Saudi Arabia.

ORCID-Profile: Mohammed Alnuhait

Zitieren

APA

Alhuthali, A., Alqurashi, B., Banoun, Y., Almuylibi, Z., Sait, H., Al-Sobhi, B., & Alnuhait, M. (2026). Trastuzumab Deruxtecan‐Induced Pneumonitis: Case Series. Clinical Case Reports, 14(3). https://doi.org/10.1002/ccr3.72168

Vancouver

Alhuthali A, Alqurashi B, Banoun Y, Almuylibi Z, Sait H, Al-Sobhi B, et al. Trastuzumab Deruxtecan‐Induced Pneumonitis: Case Series. Clinical Case Reports. 2026;14(3). doi:10.1002/ccr3.72168

BibTeX
@article{Alhuthali2026,
  author = {Alhuthali, Abeer and Alqurashi, Bushra and Banoun, Yusra and Almuylibi, Ziyad and Sait, Haneen and Al-Sobhi, Bayader and Alnuhait, Mohammed},
  title = {Trastuzumab Deruxtecan‐Induced Pneumonitis: Case Series},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/ccr3.72168}
}
Kostenlos starten →